Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_assertion wasGeneratedBy ECO_0000203 NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_assertion wasDerivedFrom befree-20150227 NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_assertion SIO_000772 24265321 NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_assertion evidence source_evidence_literature NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.
- NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_assertion description "[Our findings validate the hypothesis that an altered ceramide/S1P balance is an important feature of human cancers and support the development of SPHK1 inhibitors as antiangiogenic agents for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810053.RAAfyODSslD-GnZ4irBY1xpBbGE3QIv1g8rwv_HvPcVcw130_provenance.